Coya Therapeutics (COYA) Stock Forecast, Price Target & Predictions
COYA Stock Forecast
Coya Therapeutics stock forecast is as follows: an average price target of $18.00 (represents a 196.05% upside from COYA’s last price of $6.08) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.
COYA Price Target
COYA Analyst Ratings
Buy
Coya Therapeutics Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Sep 16, 2024 | Raghuram Selvaraju | H.C. Wainwright | $18.00 | $6.12 | 194.12% | 196.05% |
10
Coya Therapeutics Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 1 |
Avg Price Target | - | $18.00 | $18.00 |
Last Closing Price | $6.08 | $6.08 | $6.08 |
Upside/Downside | -100.00% | 196.05% | 196.05% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Sep 16, 2024 | H.C. Wainwright | - | Buy | Initialise |
Jun 12, 2024 | Rodman & Renshaw | - | Buy | Initialise |
Jun 08, 2023 | Chardan Capital | Buy | Buy | Hold |
10
Coya Therapeutics Financial Forecast
Coya Therapeutics Revenue Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | |
---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | $6.00M |
Avg Forecast | $450.00K | $3.17M | $1.63M | $133.33K | $100.00K | $1.88M | $2.75M | $7.50M |
High Forecast | $450.00K | $3.17M | $1.63M | $133.33K | $100.00K | $1.88M | $2.75M | $7.50M |
Low Forecast | $450.00K | $3.17M | $1.63M | $133.33K | $100.00K | $1.88M | $2.75M | $7.50M |
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
Surprise % | - | - | - | - | - | - | - | 0.80% |
Forecast
Coya Therapeutics EBITDA Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | |
---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
EBITDA | - | - | - | - | - | - | - | $2.02M |
Avg Forecast | $225.00K | $1.58M | $816.67K | $66.67K | $50.00K | $937.50K | $1.38M | $3.75M |
High Forecast | $225.00K | $1.58M | $816.67K | $66.67K | $50.00K | $937.50K | $1.38M | $3.75M |
Low Forecast | $225.00K | $1.58M | $816.67K | $66.67K | $50.00K | $937.50K | $1.38M | $3.75M |
Surprise % | - | - | - | - | - | - | - | 0.54% |
Forecast
Coya Therapeutics Net Income Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | |
---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
Net Income | - | - | - | - | - | - | - | $1.27M |
Avg Forecast | $-6.90M | $-2.28M | $-4.87M | $-5.48M | $-4.60M | $-5.51M | $-2.59M | $3.92M |
High Forecast | $-6.90M | $-2.28M | $-4.87M | $-5.48M | $-4.60M | $-5.51M | $-2.59M | $3.92M |
Low Forecast | $-6.90M | $-2.28M | $-4.87M | $-5.48M | $-4.60M | $-5.51M | $-2.59M | $3.92M |
Surprise % | - | - | - | - | - | - | - | 0.32% |
Forecast
Coya Therapeutics SG&A Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | |
---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
SG&A | - | - | - | - | - | - | - | $2.38M |
Avg Forecast | $484.32K | $3.41M | $1.76M | $143.50K | $107.63K | $2.02M | $2.96M | $8.07M |
High Forecast | $484.32K | $3.41M | $1.76M | $143.50K | $107.63K | $2.02M | $2.96M | $8.07M |
Low Forecast | $484.32K | $3.41M | $1.76M | $143.50K | $107.63K | $2.02M | $2.96M | $8.07M |
Surprise % | - | - | - | - | - | - | - | 0.29% |
Forecast
Coya Therapeutics EPS Forecast
Quarter
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | |
---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
EPS | - | - | - | - | - | - | - | $0.09 |
Avg Forecast | $-0.45 | $-0.15 | $-0.32 | $-0.36 | $-0.30 | $-0.36 | $-0.17 | $0.26 |
High Forecast | $-0.45 | $-0.15 | $-0.32 | $-0.36 | $-0.30 | $-0.36 | $-0.17 | $0.26 |
Low Forecast | $-0.45 | $-0.15 | $-0.32 | $-0.36 | $-0.30 | $-0.36 | $-0.17 | $0.26 |
Surprise % | - | - | - | - | - | - | - | 0.34% |
Forecast
Coya Therapeutics Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
INAB | IN8bio | $0.32 | $14.00 | 4275.00% | Buy |
HLVX | HilleVax | $1.82 | $32.00 | 1658.24% | Hold |
LIFE | aTyr Pharma | $1.90 | $11.00 | 478.95% | Buy |
INZY | Inozyme Pharma | $2.69 | $14.67 | 445.35% | Buy |
DRMA | Dermata Therapeutics | $1.15 | $6.00 | 421.74% | Buy |
OPT | Opthea | $3.13 | $14.00 | 347.28% | Buy |
STRO | Sutro Biopharma | $2.53 | $11.14 | 340.32% | Buy |
GANX | Gain Therapeutics | $1.62 | $7.00 | 332.10% | Buy |
CUE | Cue Biopharma | $1.03 | $4.33 | 320.39% | Buy |
FENC | Fennec Pharmaceuticals | $4.72 | $15.75 | 233.69% | Buy |
TCRX | TScan Therapeutics | $3.94 | $12.00 | 204.57% | Buy |
ABOS | Acumen Pharmaceuticals | $2.31 | $7.00 | 203.03% | Buy |
COYA | Coya Therapeutics | $6.08 | $18.00 | 196.05% | Buy |
DAWN | Day One Biopharmaceuticals | $13.34 | $38.80 | 190.85% | Buy |
ELYM | Eliem Therapeutics | $5.11 | $13.00 | 154.40% | Buy |
TERN | Terns Pharmaceuticals | $5.71 | $14.25 | 149.56% | Buy |
CNTA | Centessa Pharmaceuticals | $18.19 | $23.25 | 27.82% | Buy |